Toggle navigation
Home
About Wayshine
About Us
Our People
Our Science
Pipeline
Clinical Trials
WSD0922 PhaseIIa
WSD0922-102 Phase I/II
WSD0922-103 Phase I
WS2202 Phase II
WSD0628 Phase I
Media
Media Release
Events
Job Vacancy
Contact us
中文
CTR20253499
一项评估WSD0922-FU联合奥希替尼治疗局部晚期或转移性非小细胞肺腺癌受试者的安全性、耐受性、药代动力学和有效性的I/II期研究
https://www.chinadrugtrials.org.cn/clinicaltrials.prosearch.dhtml
Contact: Wayshine Biopharm
Address：Room 903, Chenkai International Building, No. 355 Hongqiao Road, Xuhui District, Shanghai
Mail：wsd@wayshinebiopharm.com
About Wayshine
About Us
Our People
Our Science
WeChat Official Account
Copyright © 2026 Wayshine Biopharm International Ltd. Cayman
